| . | Pre-ablation . | Post-ablation . | P-value . | 95% CI . |
|---|---|---|---|---|
| LVEF (%) . | . | . | . | . |
| All patients | 33 (25–38) | 50 (35–55) | <0.001 | 13–18 |
| LA fibrosis (+) | 32 (25–39) | 40 (30–55) | <0.001 | 6–14 |
| LA fibrosis (−) | 36 (25–38) | 54 (45–60) | <0.001 | 16–21 |
| LA (mm) | ||||
| All patients | 48 ± 5 | 45 ± 8 | 0.002 | −1.0 to −4.3 |
| LA fibrosis (+) | 50 ± 5 | 46 ± 7 | 0.023 | −0.5 to −5.5 |
| LA fibrosis (−) | 47 ±6 | 44 ±9 | 0.035 | −0.2 to −4.7 |
| LVED (mm) | ||||
| All patients | 56 ± 9 | 55 ± 8 | 0.359 | −2.3 to 0.8 |
| LA fibrosis (+) | 56 ± 7 | 54 ± 9 | 0.918 | −2.4 to 2.6 |
| LA fibrosis (−) | 57 ±10 | 55 ±8 | 0.242 | −3.3 to 0.9 |
| Mitral regurgitation, n (%) | ||||
| All patients | ||||
| Non | 2 (2) | 1 (1) | 0.048 | −0.223 to −0.001 |
| Mild | 63 (62) | 73 (75) | ||
| Moderate | 32 (32) | 19 (19) | ||
| Severe | 4 (4) | 5 (5) | ||
| LA fibrosis (+) | ||||
| Non | 0 (0) | 0 (0) | 0.786 | −0.18 to 0.23 |
| Mild | 20 (54) | 22 (61) | ||
| Moderate | 16 (43) | 11 (31) | ||
| Severe | 1 (3) | 3 (8) | ||
| LA fibrosis (−) | ||||
| Non | 2 (3) | 1 (2) | 0.017 | −0.29 to −0.03 |
| Mild | 43 (67) | 51 (82) | ||
| Moderate | 16 (25) | 8 (13) | ||
| Severe | 3 (5) | 2 (3) | ||
| . | Pre-ablation . | Post-ablation . | P-value . | 95% CI . |
|---|---|---|---|---|
| LVEF (%) . | . | . | . | . |
| All patients | 33 (25–38) | 50 (35–55) | <0.001 | 13–18 |
| LA fibrosis (+) | 32 (25–39) | 40 (30–55) | <0.001 | 6–14 |
| LA fibrosis (−) | 36 (25–38) | 54 (45–60) | <0.001 | 16–21 |
| LA (mm) | ||||
| All patients | 48 ± 5 | 45 ± 8 | 0.002 | −1.0 to −4.3 |
| LA fibrosis (+) | 50 ± 5 | 46 ± 7 | 0.023 | −0.5 to −5.5 |
| LA fibrosis (−) | 47 ±6 | 44 ±9 | 0.035 | −0.2 to −4.7 |
| LVED (mm) | ||||
| All patients | 56 ± 9 | 55 ± 8 | 0.359 | −2.3 to 0.8 |
| LA fibrosis (+) | 56 ± 7 | 54 ± 9 | 0.918 | −2.4 to 2.6 |
| LA fibrosis (−) | 57 ±10 | 55 ±8 | 0.242 | −3.3 to 0.9 |
| Mitral regurgitation, n (%) | ||||
| All patients | ||||
| Non | 2 (2) | 1 (1) | 0.048 | −0.223 to −0.001 |
| Mild | 63 (62) | 73 (75) | ||
| Moderate | 32 (32) | 19 (19) | ||
| Severe | 4 (4) | 5 (5) | ||
| LA fibrosis (+) | ||||
| Non | 0 (0) | 0 (0) | 0.786 | −0.18 to 0.23 |
| Mild | 20 (54) | 22 (61) | ||
| Moderate | 16 (43) | 11 (31) | ||
| Severe | 1 (3) | 3 (8) | ||
| LA fibrosis (−) | ||||
| Non | 2 (3) | 1 (2) | 0.017 | −0.29 to −0.03 |
| Mild | 43 (67) | 51 (82) | ||
| Moderate | 16 (25) | 8 (13) | ||
| Severe | 3 (5) | 2 (3) | ||
Data are given as mean ± SD and median with (IQR).
AF, atrial fibrillation; CI, confidence interval; IQR, interquartile range; LA, left atrium; LVED, left ventricular end-diastolic; LVEF, left ventricular ejection fraction; SD, standard deviation.
| . | Pre-ablation . | Post-ablation . | P-value . | 95% CI . |
|---|---|---|---|---|
| LVEF (%) . | . | . | . | . |
| All patients | 33 (25–38) | 50 (35–55) | <0.001 | 13–18 |
| LA fibrosis (+) | 32 (25–39) | 40 (30–55) | <0.001 | 6–14 |
| LA fibrosis (−) | 36 (25–38) | 54 (45–60) | <0.001 | 16–21 |
| LA (mm) | ||||
| All patients | 48 ± 5 | 45 ± 8 | 0.002 | −1.0 to −4.3 |
| LA fibrosis (+) | 50 ± 5 | 46 ± 7 | 0.023 | −0.5 to −5.5 |
| LA fibrosis (−) | 47 ±6 | 44 ±9 | 0.035 | −0.2 to −4.7 |
| LVED (mm) | ||||
| All patients | 56 ± 9 | 55 ± 8 | 0.359 | −2.3 to 0.8 |
| LA fibrosis (+) | 56 ± 7 | 54 ± 9 | 0.918 | −2.4 to 2.6 |
| LA fibrosis (−) | 57 ±10 | 55 ±8 | 0.242 | −3.3 to 0.9 |
| Mitral regurgitation, n (%) | ||||
| All patients | ||||
| Non | 2 (2) | 1 (1) | 0.048 | −0.223 to −0.001 |
| Mild | 63 (62) | 73 (75) | ||
| Moderate | 32 (32) | 19 (19) | ||
| Severe | 4 (4) | 5 (5) | ||
| LA fibrosis (+) | ||||
| Non | 0 (0) | 0 (0) | 0.786 | −0.18 to 0.23 |
| Mild | 20 (54) | 22 (61) | ||
| Moderate | 16 (43) | 11 (31) | ||
| Severe | 1 (3) | 3 (8) | ||
| LA fibrosis (−) | ||||
| Non | 2 (3) | 1 (2) | 0.017 | −0.29 to −0.03 |
| Mild | 43 (67) | 51 (82) | ||
| Moderate | 16 (25) | 8 (13) | ||
| Severe | 3 (5) | 2 (3) | ||
| . | Pre-ablation . | Post-ablation . | P-value . | 95% CI . |
|---|---|---|---|---|
| LVEF (%) . | . | . | . | . |
| All patients | 33 (25–38) | 50 (35–55) | <0.001 | 13–18 |
| LA fibrosis (+) | 32 (25–39) | 40 (30–55) | <0.001 | 6–14 |
| LA fibrosis (−) | 36 (25–38) | 54 (45–60) | <0.001 | 16–21 |
| LA (mm) | ||||
| All patients | 48 ± 5 | 45 ± 8 | 0.002 | −1.0 to −4.3 |
| LA fibrosis (+) | 50 ± 5 | 46 ± 7 | 0.023 | −0.5 to −5.5 |
| LA fibrosis (−) | 47 ±6 | 44 ±9 | 0.035 | −0.2 to −4.7 |
| LVED (mm) | ||||
| All patients | 56 ± 9 | 55 ± 8 | 0.359 | −2.3 to 0.8 |
| LA fibrosis (+) | 56 ± 7 | 54 ± 9 | 0.918 | −2.4 to 2.6 |
| LA fibrosis (−) | 57 ±10 | 55 ±8 | 0.242 | −3.3 to 0.9 |
| Mitral regurgitation, n (%) | ||||
| All patients | ||||
| Non | 2 (2) | 1 (1) | 0.048 | −0.223 to −0.001 |
| Mild | 63 (62) | 73 (75) | ||
| Moderate | 32 (32) | 19 (19) | ||
| Severe | 4 (4) | 5 (5) | ||
| LA fibrosis (+) | ||||
| Non | 0 (0) | 0 (0) | 0.786 | −0.18 to 0.23 |
| Mild | 20 (54) | 22 (61) | ||
| Moderate | 16 (43) | 11 (31) | ||
| Severe | 1 (3) | 3 (8) | ||
| LA fibrosis (−) | ||||
| Non | 2 (3) | 1 (2) | 0.017 | −0.29 to −0.03 |
| Mild | 43 (67) | 51 (82) | ||
| Moderate | 16 (25) | 8 (13) | ||
| Severe | 3 (5) | 2 (3) | ||
Data are given as mean ± SD and median with (IQR).
AF, atrial fibrillation; CI, confidence interval; IQR, interquartile range; LA, left atrium; LVED, left ventricular end-diastolic; LVEF, left ventricular ejection fraction; SD, standard deviation.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
